Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Audio By Carbonatix

LAKE FOREST, Ill.--(BUSINESS WIRE)--Mar 3, 2026--

Assertio Holdings, Inc. (“Assertio”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1 (646) 307-1963. The call ID is 3278948.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260303479892/en/

CONTACT: Investor Contact

Longacre Square Partners

[email protected]

KEYWORD: ILLINOIS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH NEUROLOGY ONCOLOGY

SOURCE: Assertio Holdings, Inc.

Copyright Business Wire 2026.

PUB: 03/03/2026 04:30 PM/DISC: 03/03/2026 04:30 PM

http://www.businesswire.com/news/home/20260303479892/en